DEA wants more psychedelics; Marijuana amendments in Congress; MN cannabis rules underway; PA licensing bill advances; Drug legalization handbook
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.
Support our work at https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Rep. Earl Blumenauer (D-OR), a founding co-chair of the Congressional Cannabis Caucus, announced he won’t run for reelection next year. His co-chairs of the caucus and outside advocates spoke to Marijuana Moment about his legacy and carrying the torch forward.
The Drug Enforcement Administration is moving to dramatically increase the amount of marijuana compounds and psychedelics like psilocybin and ibogaine that can be produced this year for research—on top of massive expansions already announced previously.
The House Rules Committee is set to consider amendments to remove the block on marijuana sales in Washington, D.C. and to end the practice of drug testing federal job applicants for cannabis.
Read full article on Marijuana Moment
